These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1186596)

  • 1. [Drugs: their development, safety, and effectiveness].
    Med Monatsschr; 1975 Sep; 29(9):385-6. PubMed ID: 1186596
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies on the biotransformation of drugs and its significance in pharmaceutical industry].
    Hansen T
    Nord Med; 1967 Nov; 78(47):1549-54. PubMed ID: 6075279
    [No Abstract]   [Full Text] [Related]  

  • 3. [Do we need new drugs?].
    Deck K
    Fortschr Med; 1983 Jan; 101(3):49-50, 87. PubMed ID: 6826129
    [No Abstract]   [Full Text] [Related]  

  • 4. [Liability for drug-related damage by the pharmaceutical industry and the physician].
    Dahse G
    Beitr Gerichtl Med; 1982; 40():21-2. PubMed ID: 7165639
    [No Abstract]   [Full Text] [Related]  

  • 5. [About medicines. Production, advertising, abuse and side effects of our drugs].
    Spegg H
    Dtsch Krankenpflegez; 1974 Jun; 27(6):290-7. PubMed ID: 4495221
    [No Abstract]   [Full Text] [Related]  

  • 6. [Research of for the discovery of new drugs and research for the development and production of drugs].
    Setnikar I
    Boll Chim Farm; 1971 Sep; 110(9):503-9. PubMed ID: 5137987
    [No Abstract]   [Full Text] [Related]  

  • 7. [Drug samples for physicians].
    Schulz G
    Ther Ggw; 1969 Feb; 108(2):299-302. PubMed ID: 5792520
    [No Abstract]   [Full Text] [Related]  

  • 8. Metabolism and toxicity of drugs. Two decades of progress in industrial drug metabolism.
    Baillie TA
    Chem Res Toxicol; 2008 Jan; 21(1):129-37. PubMed ID: 18052111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Proposals for the legal control of the testing and introduction of drugs based on a comparison of drug laws in other countries].
    Burow W; Lüllmann H
    Schriftenr Geb Off Gesundheitswes; 1971; 31():1-64. PubMed ID: 5153578
    [No Abstract]   [Full Text] [Related]  

  • 10. [Drugs: from research to consumer].
    Krankenpflege (Frankf); 1978 Nov; 32(11):366-8. PubMed ID: 213643
    [No Abstract]   [Full Text] [Related]  

  • 11. [Changes in medicine and current advances in the development of drugs].
    von Schlichtegroll A
    Med Welt; 1979 Mar; 30(9):324-8. PubMed ID: 763142
    [No Abstract]   [Full Text] [Related]  

  • 12. A basic approach to the development of drugs.
    Ariëns EJ
    Ann Ist Super Sanita; 1967; 3(3):412-42. PubMed ID: 5618700
    [No Abstract]   [Full Text] [Related]  

  • 13. Influence of formulation factors on the availability of drugs from topical preparations.
    Asche H; Botta L; Rettig H; Weirich EG
    Pharm Acta Helv; 1985; 60(8):232-7. PubMed ID: 4070318
    [No Abstract]   [Full Text] [Related]  

  • 14. [Communication of the board of directors of the Pharmacological Society and the commission drawing up directions for testing of new drugs].
    Pharmakotherapia; 1964; 2(1):195-207. PubMed ID: 5875713
    [No Abstract]   [Full Text] [Related]  

  • 15. Road traffic safety and the pharmaceutical industry.
    Stonier PD
    Int Clin Psychopharmacol; 1988 May; 3 Suppl 1():133-40. PubMed ID: 3403946
    [No Abstract]   [Full Text] [Related]  

  • 16. [Drug testing: progress and expectations].
    Aschenbrenner R; Lewandowski G
    Internist (Berl); 1973 Jan; 14(1):1-5. PubMed ID: 4576793
    [No Abstract]   [Full Text] [Related]  

  • 17. Drugs in nursing: drug bioavailability.
    Brodie MJ
    Nursing (Lond); 1982 Aug; 2(4):107-9. PubMed ID: 6926570
    [No Abstract]   [Full Text] [Related]  

  • 18. [The new drug law of the German Democratic Republic and its significance for the evaluation of drugs].
    Richter J
    Z Arztl Fortbild (Jena); 1965 Apr; 59(8):413-20. PubMed ID: 5887305
    [No Abstract]   [Full Text] [Related]  

  • 19. The pharmaceutical industry--to whom is it accountable?
    Hayes TA
    N Engl J Med; 2000 Nov; 343(19):1416; discussion 1417. PubMed ID: 11183881
    [No Abstract]   [Full Text] [Related]  

  • 20. [Is openness in the drug market possible?].
    Dölle W; Schwabe U
    Internist (Berl); 1986 Jan; 27(1):21-31. PubMed ID: 3514513
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.